Trials / Sponsors / HTA Co., Ltd.
HTA Co., Ltd.
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer Prostate Cancer | Phase 3 | 2024-12-19 |
| Active Not Recruiting | Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs NETs | Phase 3 | 2024-01-08 |
| Recruiting | A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxyt NETS Ga68 Lu177 | Phase 3 | 2023-12-12 |
| Completed | A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection MCI, AD | Phase 1 | 2023-11-06 |
| Unknown | Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer Prostate Cancer | Phase 3 | 2023-10-20 |
| Completed | Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT Bone Metastases | Phase 3 | 2021-03-29 |